Non-Tariff Measure

NTM classification
P13: Production and post-production requirements to export 
Date when the measure came into force
01 July 2008 
Publication where the measure is specified
Statutory Instrument 57 of 2008 
Regulation where the measure is specified
Medicines and Allied Substances Control (Import and Export of Medicines) Regulations, 2008. 
Country/Region applying the measure
Zimbabwe 
The rationale of the measure
These regulations shall apply to all medicines other than—
(a) those controlled in terms of the Dangerous Drugs Act [Chapter 15:02]; and
(b) psychotropic substances controlled in terms of the Medicines and Allied Substances
Control (General) Regulations, 1991; and
(c) medicines imported in terms of section 75 of the Act for a named person; and
(d) medicines imported by an individual for personal use. 
Coded list of objectives
X: For purposes n.e.s. 
Description of the measure
4.(1) Subject to section 13, no person shall import into or export from Zimbabwe any
registered medicine otherwise than in accordance with the terms and conditions of a permit
issued by the Authority.

5.(1)(b) in the case of an application for an export permit, in Form I.E.3 and shall be
accompanied by the fee prescribed in the Second Schedule

5 (4) An application for the issue of an export permit shall state, for each medicine to be
exported—
(a) the name and address of the exporter; and
(b) the trade name or proprietary name of the medicine, if any; and
(c) the International Non-Proprietary Name (INN) or generic name of the medicine; and
(d) its strength; and
(e) the total quantity of the medicine; and
(f) the name and address of the manufacturer; and
(g) the Zimbabwean registration number; and
(h) the cost, insurance, freight (CIF) value of the consignment; and
(i) the port of entry 
Reference of the measure
Art 4(1), 5(1)(b) and 5(4) 
Measure also domestic
Yes 

Products affected by the measure.

Code Product Partial coverage Partial coverage indication Date in Date out
3003.10.00 Containing penicillins or derivatives thereof, with a penicillinic acid structure, or streptomycin or their derivatives No    
3003.20.00 Containing other antibiotics No    
3003.31.00 Containing insulin No    
3003.39.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3003.39.90 Other No    
3003.40.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3003.40.90 Other No    
3003.90.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3003.90.20 Preparations containing a drug not categorised as prescription preparation No    
3003.90.90 Other No    
3004.10.00 Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives No    
3004.20.00 Containing other antibiotics No    
3004.31.00 Containing insulin No    
3004.32.00 Containing corticosteroid hormones, their derivatives or structural analogues No    
3004.39.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3004.39.90 Other No    
3004.40.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3004.40.90 Other No    
3004.50.00 Other medicaments containing vitamins or other products of heading 29.36 No    
3004.90.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No    
3004.90.20 Preparations containing a drug not categorised as prescription preparation No    
3004.90.90 Other No    
Description
These regulations apply to all medicines other than
(a)Psychotropic substances (Amphetamine, Dexamphetamine, Methamphetamine, Methylphenidate, Phencyclidine, Amobarbital, Cyclobarbital, Pentobarbital, Secobarbital, Amfepramone, Barbital, Ethinamate, Meprobamate, Methylphenobarbital, Phenobarbital, Pipradrol)

(b)Drugs controlled in terns of the Dangerous Drug Act ( coca leaves; “Indian hemp”, “bhang”, “camba”, “dagga”, “mbanje” or “intsangu”, resins obtained therefrom and all preparations of which such resins form the base; raw opium;1.Medicinal opium.
2. Any medicinal extract or tincture derived from the plant Cannabis sativa L. and any
preparation, not being a preparation capable of external use only, made from such
medicinal extract or tincture.
3. Morphine and its salts.
4. Cocaine (including synthetic cocaine) and ecgonine and their respective salts, and the
esters of ecgonine and their respective salts. (For the purposes of this Act, the expression
“ecgonine” means laevo-ecgonine and includes any derivatives of ecgonine from which it
may be recovered industrially.)
5. Any solution or dilution of morphine or cocaine or their salts in an inert substance,
whether liquid or solid, containing any proportion of morphine or cocaine, and any
preparation, admixture, extract or other substance (not being such a solution or dilution as
aforesaid) containing not less than one-fifth per centum of morphine or one-tenth per
centum of cocaine or of ecgonine.
6. Diacetylmorphine (commonly known as diamorphine or heroin) and the other esters of
morphine and their respective salts.
7. Dihydrohydroxycodeinone (also known as oxycodone);
Dihydrocodeinone (also known as hydrocodone);
Dihydromorphinone (also known as hydromorphone);
Acetyldihydrocodeinone;
Dihydromorphine;
their esters, and the salts of any of these substances and of their esters.
8. Morphine-N-oxide (commonly known as genomorphine) also the morphine-N-oxide
derivatives, and the other pentavalent nitrogen morphine derivatives. )

(c) Any medicines exempted from the operation of any or all of the provisions of the Medicines and Allied Substance Control Act
(d) The Regulations also excludes medicines imported by an individual for personal use. 

Countries/Regions affected by the measure.

Inclusion/Exclusion Country Date in Date out
Inclusion Entire world    
Description
All countries